止血剂市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPHE100001419
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 145
Buy Now

2019年止血剂市场价值为22.060亿美元,预计到2027年将达到35.5741亿美元;预计 2020 年至 2027 年复合年增长率为 6.3%。

止血剂在外科手术过程中发挥着基础性作用,因为它可以实现卓越的失血管理。该产品具有术中和术后应用。止血钳可用于渗出性静脉型出血、生面扩散性出血、骨出血和针孔出血。止血剂市场的增长归因于慢性病患病率的上升,这导致外科手术数量的增加、政府采取的战略举措的数量以及医院数量的增加。然而,由于新兴国家缺乏产品意识以及缺乏有利可图的报销,市场的增长预计将受到限制。

止血剂市场预计将出现大幅增长疫情后的增长。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

利润丰厚的地区止血剂市场

市场洞察

止血剂在医疗保健领域的不断增长的应用将推动止血剂市场的增长

外科手术数量的增加也增加了止血剂的使用。膝关节置换等骨科手术等手术数量增加髋关节有助于市场增长。由于各种疾病或交通事故造成的损伤和损伤而进行的截肢手术。例如,根据美国医疗保健研究和质量局的数据,美国每年进行约 600,000 例膝关节置换手术。

此外,由于与运动、年龄相关的功能障碍和职业伤害相关的肌肉骨骼疾病的增加,手术数量也在增加。例如,根据关节炎基金会的数据,2017 年约有 5400 万成年人被诊断患有关节炎。此外,近 30 万婴儿和儿童患有关节炎或风湿病。

老年人口的增加可能是外科手术数量增加的一个重要因素。膝关节置换手术正在针对老年人群的关节恶化进行。根据该报告,“美国的老龄化”人口资料局公布的数据显示,不断增长的人口(65 岁及以上的人)可能会重塑美国老年人口的情况。类风湿性关节炎(RA)、强直性脊柱炎(AS)和老年人骨质疏松症等疾病的增加正在推动手术数量的增加。例如,根据 Healthline Media 2018 年发布的报告,每年每 10 万人中就有 41 人患有类风湿性关节炎 (RA),近 130 万美国人患有类风湿性关节炎。同样,根据国际骨质疏松基金会(2018)的数据,骨质疏松症估计影响全球 2 亿女性,其中近十分之一的女性年龄在 60 岁以上,五分之一的女性年龄在 70 岁以上,五分之二的 80 岁以上女性和三分之二的 90 岁以上女性。因此,由于上述因素,预计止血剂市场在预测期内将会增长。

运动损伤发生率的上升是由周末运动员、职业运动员、青少年、在社会上玩耍的儿童以及有时是成年人造成的。大多数运动损伤都是骨科损伤,包括肿胀、疼痛、拉伤、扭伤、骨折、韧带断裂等。这些损伤大致分为急性和慢性类型。伤害或损伤是由水上运动、水上足球、板球、篮球、橄榄球、体育比赛等运动引起的。例如,根据国际足联(FIFA)的数据显示,运动损伤主要是由足球造成的。

此外,据估计,脚踝扭伤是全世界足球运动员最常遭受的伤害。在美国的急诊科,大约。治疗了 240,000 名伤员;其中,估计骨折近48,810例,扭伤和扭伤约79,400例。劳损、脱位5000例。

此外,根据 BMJ Publishing Group Ltd (2017) 发布的报告,近 8% 的运动员在奥运会期间遭受过一次伤害, 2016 年里约热内卢夏季奥运会。另外,根据斯坦福儿童健康中心2018年发布的数据,在美国,有近350万儿童和青少年遭受过14岁及以下年龄段的伤害。报告还报告说,体育运动中受伤率最高的是接触和碰撞。在个人体育和娱乐活动中发生严重伤害。此外,大约 62% 的运动相关伤害发生在练习期间。

同样,在板球运动中,投球手更容易因腿部、肘部和肩膀的重复运动而受伤。观察到的典型火腿和损伤包括撞击综合征、肩袖撕裂、脚踝扭伤以及肘部内侧韧带损伤。因此,平均有 10% 的板球运动员可能在赛场上的任何时间点遭受损伤,大约有 10% 的板球运动员可能在赛场上的任何时间点遭受损伤。 15% 的事故是由快速投球手造成的。

此外,据斯坦福儿童健康中心报道,有近 17 万名 5 至 14 岁儿童因篮球受伤而在医院急诊室接受治疗。同样,大约 47,000 名因直排轮滑相关伤害的儿童接受了治疗。同样,大约 65,000 名因蹦床受伤的儿童在医院急诊室接受治疗。

在分析不同组织提供的事实和数据后,预计止血剂市场在预测期内可能会出现良好的增长。

p>

基于产品的见解

就产品而言,止血剂市场分为基于凝血酶的止血剂、组合止血剂、基于明胶的止血剂、基于胶原蛋白的止血剂和基于氧化再生纤维素的止血剂。 2019 年,按产品划分,基于凝血酶的止血剂占据了最大的市场份额。

按产品划分的止血剂市场 – 2019 年和 2027 年


基于最终用户的见解

就最终用户而言,止血剂市场是分为医院和医院诊所和其他最终用户。医院和诊所在全球市场的最终用户细分市场中占有最大份额。

战略见解

止血器市场参与者正在采用该产品推出和扩张战略,以满足全球不断变化的客户需求,这也使他们能够在全球范围内维持其品牌名称。

止血剂市场 -按产品

  • 基于凝血酶的止血剂
  • 组合止血剂
  • 基于明胶的止血剂
  • 基于胶原蛋白的止血剂
  • 基于氧化再生纤维素的止血剂

止血剂市场 -由最终用户提供

  • 医院和医院诊所
  • 门诊手术中心
  • 其他最终用户

止血剂市场 -按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
  • < /ul>

    公司简介

    • BD
    • B. Braun Melsungen AG
    • 百特国际公司
    • Integra Life Sciences Corporation
    • 泰利福公司
    • 强生公司Johnson Services, Inc.
    • Biom'up
    • ZMedica, LL
    • Gelita Medical
    • 辉瑞公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are hemostats?

Hemostats refers to surgical supplies consisting of hemostatic agents and their delivering systems that are present in the form of pads, sponges, patches, powders, liquids or others. These hemostats are made from various blood clotting materials such as collagen, thrombin, cellulose, gelatin and others.

What are the driving factors for the hemostats market across the globe?

Rise in healthcare insurance providers, technological advancement and growing number of surgery procedures are projected to drive the growth of the global hemostats market during the forecast period. Moreover, growth of healthcare infrastructure among the untapped nations and increased initiatives taken up by governments are expected to fuel the growth of this market during the forecast period.

What is the average cost of Hemostats?

There are various types of hemostats available in the market priced within a range of US$ 5.0 to US$ 150.0 depending upon various factors such as formulation, material composition, application areas, quantity and others.

The List of Companies - Hemostats Market

  1. Johnson & Johnson Services, Inc. (Ethicon LLC)
  2. BD
  3. Baxter
  4. B. Braun Melsungen Ag
  5. Pfizer, Inc.
  6. GELITA MEDICAL
  7. Integra Lifesciences Holdings Corporation
  8. Z-Medica, LLC
  9. Biom’up
  10. Teleflex Incorporated

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports